Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,646 public trials 848 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

NCT06588205

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, +11 more
Locations
  • A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia Alessandria, Italy
  • A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
  • I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
  • ASST Spedali Civili - S.C. Ematologia Brescia, Italy
View all 20 locations
View Trial Details
Recruiting

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

NCT06008691

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Istituto Oncologico del Mediterraneo SPA - Oncologico Viagrande, Catania, Italy
  • Ospedale SS. Cosma e Damiano - Ospedale San Jacopo - SOS Oncoematologia ed ematologia clinica Pescia, Pistoia, Italy
  • A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia Alessandria, Italy
  • AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
View all 61 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma

NCT06392477

Conditions
B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Investigational Site Number : 001-203 Camperdown, New South Wales, Australia
  • Investigational Site Number : 001-202 Townsville, Queensland, Australia
  • Investigational Site Number : 001-205 Adelaide, South Australia, Australia
  • Investigational Site Number : 001-204 Melbourne, Victoria, Australia
View all 16 locations
View Trial Details
Recruiting

A Study in Leukemia Patients With Karonudib

NCT04077307

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Rigshospitalet Copenhagen University Hospital Copenhagen, Denmark
  • University Clinical Center Belgrade Belgrade, Serbia
  • University Clinical Center Kragujevac Kragujevac, Serbia
View Trial Details
Recruiting

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

NCT06736613

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma

NCT07189065

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Anhui Cancer Hospital (West Branch of Anhui Provincial Hospital) Hefei, Anhui, China
  • Beijing Shijitan Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital Beijing, Beijing Municipality, China
  • National Cancer Center/Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
View all 41 locations
View Trial Details

Related conditions